KEGG   PATHWAY: opi04932
Entry
opi04932                    Pathway                                
Name
Non-alcoholic fatty liver disease - Ochotona princeps (American pika)
Description
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
opi04932  Non-alcoholic fatty liver disease
opi04932

Disease
H01333  Non-alcoholic fatty liver disease
Organism
Ochotona princeps (American pika) [GN:opi]
Gene
101516596  NDUFS2; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial [KO:K03935] [EC:7.1.1.2]
101516919  [KO:K03955]
101517015  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
101517444  NDUFA10; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial [KO:K03954]
101517703  BAX; apoptosis regulator BAX [KO:K02159]
101517708  [KO:K00417]
101517745  SDHC; succinate dehydrogenase cytochrome b560 subunit, mitochondrial isoform X1 [KO:K00236]
101517779  [KO:K02271]
101517849  [KO:K09113]
101517919  NDUFB5; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial isoform X1 [KO:K03961]
101517982  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
101518296  SDHD; succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial isoform X1 [KO:K00237]
101518340  NDUFB10; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 [KO:K03966]
101518695  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
101518780  NDUFA12; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 [KO:K11352]
101518948  [KO:K07297]
101519014  [KO:K08738]
101519021  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
101519096  [KO:K02270]
101519449  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
101519452  [KO:K00419]
101519503  NDUFA4; cytochrome c oxidase subunit NDUFA4 [KO:K03948]
101519777  [KO:K02266]
101519995  [KO:K02271]
101520130  [KO:K00411] [EC:7.1.1.8]
101520164  PRKAB2; 5'-AMP-activated protein kinase subunit beta-2 isoform X1 [KO:K07199]
101520490  NDUFB9; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 isoform X1 [KO:K03965]
101520662  MLXIPL; carbohydrate-responsive element-binding protein isoform X1 [KO:K09113]
101520675  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
101520891  [KO:K00414]
101521307  NDUFS4; NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial [KO:K03937]
101521399  [KO:K02270]
101521494  SDHB; succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial isoform X1 [KO:K00235] [EC:1.3.5.1]
101521567  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
101521685  JUN; transcription factor AP-1 [KO:K04448]
101521762  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
101521864  NDUFA4L2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 [KO:K03948]
101522074  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]
101522189  NDUFV2; NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial [KO:K03943] [EC:7.1.1.2]
101522263  NDUFB3; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 [KO:K03959]
101522479  NDUFAB1; acyl carrier protein, mitochondrial [KO:K03955]
101522527  ADIPOR1; adiponectin receptor protein 1 isoform X2 [KO:K07297]
101522576  [KO:K02266]
101522590  [KO:K02273]
101522715  EIF2S1; eukaryotic translation initiation factor 2 subunit 1 [KO:K03237]
101522908  [KO:K03955]
101523181  [KO:K02268]
101523277  [KO:K02270]
101523318  NDUFA11; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 [KO:K03956]
101523365  NDUFA2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 [KO:K03946]
101523640  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
101523703  NDUFS5; NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 [KO:K03938]
101524169  NDUFS3; NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [KO:K03936] [EC:7.1.1.2]
101524207  PRKAB1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
101524227  NDUFB6; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 isoform X1 [KO:K03962]
101524339  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
101524542  [KO:K00413]
101524571  MAPK12; mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
101524628  [KO:K02270]
101524631  [KO:K02270]
101524844  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
101525099  DDIT3; DNA damage-inducible transcript 3 protein [KO:K04452]
101525120  MAPK14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
101525197  NDUFA1; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 [KO:K03945]
101525285  NDUFC2; NADH dehydrogenase [ubiquinone] 1 subunit C2 isoform X1 [KO:K03968]
101525361  NDUFC1; NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial [KO:K03967]
101525509  [KO:K07198] [EC:2.7.11.31]
101525514  [KO:K00418]
101525561  TNF; tumor necrosis factor isoform X2 [KO:K03156]
101525568  [KO:K00416]
101525667  ITCH; E3 ubiquitin-protein ligase Itchy homolog [KO:K05632] [EC:2.3.2.26]
101525684  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
101525801  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101526067  FOS; proto-oncogene c-Fos isoform X1 [KO:K04379]
101526129  PRKAG1; 5'-AMP-activated protein kinase subunit gamma-1 isoform X1 [KO:K07200]
101526158  [KO:K02263]
101526197  IRS1; insulin receptor substrate 1 [KO:K16172]
101526271  NDUFA13; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 [KO:K11353]
101526415  [KO:K00235] [EC:1.3.5.1]
101526428  [KO:K05424]
101526478  NR1H3; oxysterols receptor LXR-alpha isoform X1 [KO:K08536]
101526542  [KO:K02272]
101526600  NDUFB2; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial [KO:K03958]
101526617  [KO:K08738]
101526751  ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
101526820  PPARA; peroxisome proliferator-activated receptor alpha [KO:K07294]
101526896  [KO:K00415]
101527103  IRS2; insulin receptor substrate 2 [KO:K07187]
101527226  [KO:K08738]
101527487  EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 [KO:K08860] [EC:2.7.11.1]
101527518  [KO:K04392]
101527720  NDUFB11; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial isoform X2 [KO:K11351]
101527835  TRAF2; TNF receptor-associated factor 2 isoform X2 [KO:K03173] [EC:2.3.2.27]
101528030  [KO:K02649]
101528179  [KO:K02270]
101528266  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
101528278  NDUFV1; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial isoform X1 [KO:K03942] [EC:7.1.1.2]
101528295  CASP7; caspase-7 [KO:K04397] [EC:3.4.22.60]
101528550  NDUFB1; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 [KO:K03957]
101528938  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
101529213  IL1B; interleukin-1 beta [KO:K04519]
101529489  [KO:K02270]
101529497  GSK3A; glycogen synthase kinase-3 alpha [KO:K08822] [EC:2.7.11.26]
101529543  PRKAA2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
101529724  [KO:K02264]
101529815  NDUFA9; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial [KO:K03953]
101529822  NDUFS8; NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial [KO:K03941] [EC:7.1.1.2]
101529831  MLX; max-like protein X isoform X1 [KO:K09113]
101529904  [KO:K13375]
101529966  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
101529981  [KO:K02271]
101530066  RELA; transcription factor p65 [KO:K04735]
101530187  [KO:K02263]
101530204  BID; LOW QUALITY PROTEIN: BH3-interacting domain death agonist [KO:K04726]
101530247  PRKAG3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
101530319  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
101530376  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
101530589  NDUFB8; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial [KO:K03964]
101530642  RXRA; retinoic acid receptor RXR-alpha isoform X2 [KO:K08524]
101530811  MAP3K11; mitogen-activated protein kinase kinase kinase 11 [KO:K04419] [EC:2.7.11.25]
101530887  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]
101530924  [KO:K00411] [EC:7.1.1.8]
101531329  IL6; interleukin-6 precursor [KO:K05405]
101531453  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
101531611  NFKB1; LOW QUALITY PROTEIN: nuclear factor NF-kappa-B p105 subunit [KO:K02580]
101531621  [KO:K02267]
101531640  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
101532354  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101532428  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
101532470  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
101532509  [KO:K07415] [EC:1.14.14.-]
101532825  NDUFB4; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 [KO:K03960]
101532910  ADIPOR2; adiponectin receptor protein 2 [KO:K07297]
101533024  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
101533139  SDHA; succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X1 [KO:K00234] [EC:1.3.5.1]
101533286  [KO:K00420]
101533296  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
101533379  TGFB1; transforming growth factor beta-1 proprotein [KO:K13375]
101533464  ADIPOQ; adiponectin [KO:K07296]
101533664  [KO:K02271]
101533693  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
101533802  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
101533851  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X3 [KO:K00922] [EC:2.7.1.153]
101533865  [KO:K04526]
101534324  IL1A; interleukin-1 alpha [KO:K04383]
101534341  NDUFA3; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 [KO:K03947]
101534803  PKLR; pyruvate kinase PKLR [KO:K12406] [EC:2.7.1.40]
101535063  [KO:K03952]
101535108  [KO:K02272]
101535143  PRKAG2; 5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200]
101535381  [KO:K02265]
101535581  [KO:K04393]
101535622  NDUFA6; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 isoform X2 [KO:K03950]
101535652  NDUFS1; NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial isoform X1 [KO:K03934] [EC:7.1.1.2]
101535726  CXCL8; interleukin-8 [KO:K10030]
101535733  NDUFS6; NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial [KO:K03939]
101535821  [KO:K02271]
101535919  NDUFA5; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 isoform X1 [KO:K03949]
101536083  PRKAA1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1 [KO:K07198] [EC:2.7.11.31]
101536261  LEPR; leptin receptor isoform X1 [KO:K05062]
101536286  [KO:K03948]
101536307  [KO:K02273]
101536539  NDUFS7; NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial [KO:K03940] [EC:7.1.1.2]
101536639  SREBF1; sterol regulatory element-binding protein 1 isoform X1 [KO:K07197]
101536694  XBP1; LOW QUALITY PROTEIN: X-box-binding protein 1 [KO:K09027]
101536738  [KO:K02270]
105941493  [KO:K08738]
105941651  [KO:K03957]
105941765  [KO:K02272]
105941968  [KO:K08738]
105942350  [KO:K02267]
105942376  NDUFA7; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 [KO:K03951]
105942600  [KO:K03949]
2717275  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]
2717276  COX2; cytochrome c oxidase subunit II [KO:K02261]
2717277  COX3; cytochrome c oxidase subunit III [KO:K02262]
2717279  CYTB; cytochrome b [KO:K00412]
Compound
C00031  D-Glucose
C00162  Fatty acid
Reference
  Authors
Naik A, Kosir R, Rozman D
  Title
Genomic aspects of NAFLD pathogenesis.
  Journal
Genomics 102:84-95 (2013)
DOI:10.1016/j.ygeno.2013.03.007
Reference
  Authors
Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L
  Title
Molecular mechanisms involved in NAFLD progression.
  Journal
J Mol Med (Berl) 87:679-95 (2009)
DOI:10.1007/s00109-009-0464-1
Reference
  Authors
Seki E, Brenner DA, Karin M
  Title
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
  Journal
Gastroenterology 143:307-20 (2012)
DOI:10.1053/j.gastro.2012.06.004
Reference
  Authors
Tilg H, Moschen AR
  Title
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
  Journal
Hepatology 52:1836-46 (2010)
DOI:10.1002/hep.24001
Reference
  Authors
Larter CZ, Farrell GC
  Title
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
  Journal
J Hepatol 44:253-61 (2006)
DOI:10.1016/j.jhep.2005.11.030
Reference
  Authors
Farrell GC, van Rooyen D, Gan L, Chitturi S
  Title
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.
  Journal
Gut Liver 6:149-71 (2012)
DOI:10.5009/gnl.2012.6.2.149
Reference
  Authors
Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P
  Title
The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.
  Journal
Clin Nutr 30:6-19 (2011)
DOI:10.1016/j.clnu.2010.06.001
Reference
  Authors
Hotamisligil GS
  Title
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.
  Journal
Cell 140:900-17 (2010)
DOI:10.1016/j.cell.2010.02.034
Reference
  Authors
Parekh S, Anania FA
  Title
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
  Journal
Gastroenterology 132:2191-207 (2007)
DOI:10.1053/j.gastro.2007.03.055
Reference
  Authors
Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ
  Title
JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
  Journal
Hepatology 43:163-72 (2006)
DOI:10.1002/hep.20999
Reference
  Authors
Leung TM, Nieto N
  Title
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
  Journal
J Hepatol 58:395-8 (2013)
DOI:10.1016/j.jhep.2012.08.018
Reference
  Authors
Zafrani ES
  Title
Non-alcoholic fatty liver disease: an emerging pathological spectrum.
  Journal
Virchows Arch 444:3-12 (2004)
DOI:10.1007/s00428-003-0943-7
Reference
  Authors
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ
  Title
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
  Journal
Gastroenterology 125:437-43 (2003)
DOI:10.1016/S0016-5085(03)00907-7
Reference
  Authors
Begriche K, Igoudjil A, Pessayre D, Fromenty B
  Title
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
  Journal
Mitochondrion 6:1-28 (2006)
DOI:10.1016/j.mito.2005.10.004
Reference
PMID:9285483
  Authors
Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G
  Title
The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.
  Journal
FASEB J 11:851-7 (1997)
DOI:10.1096/fasebj.11.11.9285483
Reference
  Authors
Malhi H, Kaufman RJ
  Title
Endoplasmic reticulum stress in liver disease.
  Journal
J Hepatol 54:795-809 (2011)
DOI:10.1016/j.jhep.2010.11.005
Reference
  Authors
Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM
  Title
Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.
  Journal
Free Radic Biol Med 44:1259-72 (2008)
DOI:10.1016/j.freeradbiomed.2007.12.029
Reference
  Authors
Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E
  Title
Mitochondrial involvement in non-alcoholic steatohepatitis.
  Journal
Mol Aspects Med 29:22-35 (2008)
DOI:10.1016/j.mam.2007.09.014
Reference
  Authors
Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B
  Title
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
  Journal
Hepatology 58:1497-507 (2013)
DOI:10.1002/hep.26226
Related
pathway
opi00061  Fatty acid biosynthesis
opi00190  Oxidative phosphorylation
opi03320  PPAR signaling pathway
opi04141  Protein processing in endoplasmic reticulum
opi04151  PI3K-Akt signaling pathway
opi04210  Apoptosis
opi04668  TNF signaling pathway
opi04920  Adipocytokine signaling pathway
opi04930  Type II diabetes mellitus
KO pathway
ko04932   

DBGET integrated database retrieval system